Loading
Latest filing published 17 Mar 2025 for aTYR PHARMA INC, €14k. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jane A. Gross is a declared insider of aTYR PHARMA Inc, with filings sourced from SEC (Form 4). Over a trading history stretching from 26 April 2023 to 17 March 2025, the count stands at 2 filings.
The open-market record is one-sided, with 1 purchase worth €14k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 option exercise. So far in 2025, the count stands at 1 purchase and no sales.
The latest filing, published on 17 March 2025, reports an open-market purchase of €14k in aTYR PHARMA Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations